Investor Conference Call - 18 December 2019
17th
Dec 19
Release Date: 17/12/2019 4:40pm
Prior to the opening of the market on 18 December 2019, Pharmaxis Ltd (PXS) will announce the advice the company has received from Boehringer Ingelheim (BI) concerning BI’s future development plans for the drug it acquired from Pharmaxis in 2015.
That announcement will have the effect of lifting the current trading halt over the company’s shares.
The company will hold an investor teleconference at 9.15am (AEDT) after release of the announcement.
Conference call access information is detailed in the attached.
Categories: News and Media